Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lissa Hooi

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Molecular Oncology|March 10, 2023
Histone-lysine N-methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc-driven liver cancerDexter Kai Hao Thng, Lissa Hooi, Clarissa Chin Min Toh, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 3, 2020
A Flexi-PEGDA Upconversion Implant for Wireless Brain Photodynamic TherapyDaniel Boon Loong Teh, Akshaya Bansal, Chou Chai, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 11, 2021
Targeting RNA editing of antizyme inhibitor 1: A potential oligonucleotide-based antisense therapy for cancerDaryl Jin Tai Tay, Yangyang Song, Boya Peng, et al.
NPJ Digital Medicine|June 30, 2022
The IDentif.AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimensAgata Blasiak, Anh T L Truong, Alexandria Remus, et al.
ACS Nano|October 18, 2023
Red Blood Cell-Derived Extracellular Vesicles Display Endogenous Antiviral Effects and Enhance the Efficacy of Antiviral Oligonucleotide TherapyMigara K Jayasinghe, Chang Gao, Gracemary Yap, et al.
NPJ Precision Oncology|March 23, 2025
Functional combinatorial precision medicine for predicting and optimizing soft tissue sarcoma treatmentsSharon Pei Yi Chan, Masturah Bte Mohd Abdul Rashid, Jhin Jieh Lim, et al.
Gastroenterology|August 26, 2019
New High-Throughput Screening Identifies Compounds That Reduce Viability Specifically in Liver Cancer Cells That Express High Levels of SALL4 by Inhibiting Oxidative PhosphorylationJustin L Tan, Feng Li, Joanna Z Yeo, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Molecular Oncology|March 10, 2023
Histone-lysine N-methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc-driven liver cancerDexter Kai Hao Thng, Lissa Hooi, Clarissa Chin Min Toh, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 3, 2020
A Flexi-PEGDA Upconversion Implant for Wireless Brain Photodynamic TherapyDaniel Boon Loong Teh, Akshaya Bansal, Chou Chai, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 11, 2021
Targeting RNA editing of antizyme inhibitor 1: A potential oligonucleotide-based antisense therapy for cancerDaryl Jin Tai Tay, Yangyang Song, Boya Peng, et al.
NPJ Digital Medicine|June 30, 2022
The IDentif.AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimensAgata Blasiak, Anh T L Truong, Alexandria Remus, et al.
ACS Nano|October 18, 2023
Red Blood Cell-Derived Extracellular Vesicles Display Endogenous Antiviral Effects and Enhance the Efficacy of Antiviral Oligonucleotide TherapyMigara K Jayasinghe, Chang Gao, Gracemary Yap, et al.
NPJ Precision Oncology|March 23, 2025
Functional combinatorial precision medicine for predicting and optimizing soft tissue sarcoma treatmentsSharon Pei Yi Chan, Masturah Bte Mohd Abdul Rashid, Jhin Jieh Lim, et al.
Gastroenterology|August 26, 2019
New High-Throughput Screening Identifies Compounds That Reduce Viability Specifically in Liver Cancer Cells That Express High Levels of SALL4 by Inhibiting Oxidative PhosphorylationJustin L Tan, Feng Li, Joanna Z Yeo, et al.
Pageof 3